Adenomas are benign tumors that arise from glandular tissue. While typically non-cancerous, certain adenomas, particularly those in the colon, can progress to cancer if left untreated. Understanding the molecular mechanisms underlying this progression is crucial in cancer research. Researchers investigate genetic mutations and signaling pathways implicated in adenoma-to-carcinoma progression, aiming to identify biomarkers for early detection and targeted therapies. Advanced imaging techniques and molecular profiling help characterize adenomas and predict their malignant potential. Additionally, studying the tumor microenvironment provides insights into how adenomas interact with surrounding tissues, potentially influencing their transformation into cancer. By elucidating the complexities of adenoma biology, cancer researchers strive to develop more effective prevention and treatment strategies to reduce the burden of adenoma-associated cancers.
Title :
Pietro Salvatori, Private Practice, Italy
Title :
Jianhua Luo, University of Pittsburgh, United States
Title :
Marika Crohns, Sanofi, Germany
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom